Citation Impact
Citing Papers
Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs
2018 StandoutNobel
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA‐induced silencing complex (RISC) components argonaute‐1, argonaute‐2, PACT, TARBP1, and TARBP2 in epithelial skin cancer
2011
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA
2016
Genetic determinants of hepatic steatosis in man
2011
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Targeting autophagy in obesity: from pathophysiology to management
2018
Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing
2011
Emerging role of microRNAs in liver diseases
2009
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Regulation of microRNA function in animals
2018 Standout
SIFT web server: predicting effects of amino acid substitutions on proteins
2012 Standout
In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis
2011
The p53/miR-34 axis in development and disease
2014
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Hepatocellular carcinoma
2018 Standout
Phenotype prediction of deleterious nonsynonymous single nucleotide polymorphisms in human alcohol metabolism-related genes: a bioinformatics study
2010
Revisiting comorbidities in gout: a cluster analysis
2013
Up-regulation of Ago2 expression in gastric carcinoma
2013
Burden of liver diseases in the world
2018 Standout
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
2010 StandoutNobel
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
2020
Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction
2007
Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosis
2005
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
MicroRNAs in metabolism and metabolic disorders
2012
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress
2012
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
microRNA: Emerging therapeutic targets in acute ischemic diseases
2009
Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease
2008
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Non-alcoholic fatty liver disease across the spectrum of hypothyroidism
2012
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
2016
The NAFLD fibrosis score
2007 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism
2011
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Metazoan MicroRNAs
2018 Standout
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
2012
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
2012
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
2010
Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice
2011
Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
2020
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
NAFLD in Asia—as common and important as in the West
2013
The Noncoding RNA Revolution—Trashing Old Rules to Forge New Ones
2014 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
2005
Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells
2012
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Antibiotic resistance genes in water environment
2009
Argonaute proteins: Structural features, functions and emerging roles
2020
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
VIZR—an automated chemometric technique for metabolic profiling
2013
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
2017
The pros, cons, and many unknowns of probiotics
2019 Standout
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis
2012
Modeling neurodevelopmental disorder-associated humanAGO1mutations inCaenorhabditis elegansArgonautealg-1
2024 StandoutNobel
CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
2019
Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
2009
Regulation of immune cell function by short‐chain fatty acids
2016
Identification of a microRNA signature of renal ischemia reperfusion injury
2010
Diabetic Cardiomyopathy
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Introduction to the human gut microbiota
2017 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China
2013
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
2018
The Prevalence of Nonalcoholic Fatty Liver Disease and Relationship with Serum Uric Acid Level in Uyghur Population
2014
Sex-Specific Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
2016
MicroRNA-223 coordinates cholesterol homeostasis
2014
Thyroid Hormone Regulation of Metabolism
2014 Standout
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Demystifying the nuclear function of Argonaute proteins
2014
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Gout
2021 Standout
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
2019
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study
2014
Nonalcoholic Fatty Liver Disease
2015 Standout
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
Works of Chaohui Yu being referenced
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
2009
The role of remote ischemic preconditioning on postoperative kidney injury in patients undergoing cardiac and vascular interventions: a meta-analysis
2013
Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population
2016
Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease
2002
MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease
2008
Association between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
2012
Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study
2013
Prevalence of Nonalcoholic Fatty Liver Disease and Economy
2015
Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease
2011
Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
2016
Proteomic analysis of individual variation in normal livers of human beings using difference gel electrophoresis
2006
Argonaute proteins: potential biomarkers for human colon cancer
2010
Association of serum uric acid level with non-alcoholic fatty liver disease: A cross-sectional study
2009
Association of MicroRNA-223 Expression with Hepatic Ischemia/Reperfusion Injury in Mice
2008
Early mortality of alcoholic hepatitis: A review of data from placebo-controlled clinical trials
2010
High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study
2010
Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease
2015
Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway
2017
Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study
2016
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese
2011
Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds
2015
Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis
2016
ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease
2015
Oligonucleotide microarray: A new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance
2007
A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non‐alcoholic fatty liver disease and decreased waist circumference and waist‐to‐hip ratio
2008
Epidemiology of fatty liver in an islander population of China: a population-based case-control study.
2008
Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats
2006
Endoscopic Band Ligation Versus Pharmacological Therapy for Variceal Bleeding in Cirrhosis: A Meta-Analysis
2011
LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor
2012
Prevalence of Helicobacter pylori Infection and its Relation with Body Mass Index in a Chinese Population
2014
Regulation of Hepatic MicroRNA Expression in Response to Ischemic Preconditioning following Ischemia/Reperfusion Injury in Mice
2009
A Proton Nuclear Magnetic Resonance Metabonomics Approach for Biomarker Discovery in Nonalcoholic Fatty Liver Disease
2011
Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people.
2002
[An epidemiological survey of alcoholic liver disease in Zhejiang province].
2003
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
2016
Is the hypoxia-inducible factor-1 alpha mRNA expression activated by ethanol-induced injury, the mechanism underlying alcoholic liver disease?
2006
A case–control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease
2015